Back
Aptevo Therapeutics 10K Form
Sell
33
APVO
Aptevo Therapeutics
Last Price:
$5.14
Seasonality Move:
-31.63%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2023-11-14 | 10Q | APVO/Aptevo Therapeutics Quarterly |
| 2023-08-10 | 10Q | APVO/Aptevo Therapeutics Quarterly |
| 2023-05-11 | 10Q | APVO/Aptevo Therapeutics Quarterly |
| 2022-11-10 | 10Q | APVO/Aptevo Therapeutics Quarterly |
| 2022-08-11 | 10Q | APVO/Aptevo Therapeutics Quarterly |
| 2022-05-12 | 10Q | APVO/Aptevo Therapeutics Quarterly |
Receive APVO News And Ratings
See the #1 stock for the next 7 days that we like better than APVO
APVO Financial Statistics
Sales & Book Value
| Annual Sales: | $3.1M |
|---|---|
| Cash Flow: | $-5.2M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $9.59 |
| Price / Book: | 0.55 |
Profitability
| EPS (TTM): | -3598.31440 |
|---|---|
| Net Income (TTM): | $-23.7M |
| Gross Margin: | $12.5M |
| Return on Equity: | 0% |
| Return on Assets: | 0% |
Aptevo Therapeutics Earnings Forecast
Key Aptevo Therapeutics Financial Ratios
-
The Selling, General & Administrative Expenses for APVO have been equal to 445.50% of Gross Profit Margin.
-
Per Share Earnings over the last 11 years have been positive in 5 years.
Aptevo Therapeutics Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | APVO |
| CUSIP: | 03835L |
| Website: | aptevotherapeutics.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 0 |
| Quick Ratio: | 0 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
APVO Technical Analysis vs Fundamental Analysis
Sell
33
Aptevo Therapeutics (APVO)
is a Sell
Is Aptevo Therapeutics a Buy or a Sell?
-
Aptevo Therapeutics stock is rated a SellThe current Aptevo Therapeutics [APVO] share price is $4.84. The Score for APVO is 33, which is 34% below its historic median score of 50, and infers higher risk than normal.